BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36277035)

  • 21. Thermodynamics of firms' growth.
    Zambrano E; Hernando A; Fernández Bariviera A; Hernando R; Plastino A
    J R Soc Interface; 2015 Nov; 12(112):. PubMed ID: 26510828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Firms' participation in the Swiss COVID-19 loan programme.
    Fuhrer LM; Ramelet MA; Tenhofen J
    Swiss J Econ Stat; 2021; 157(1):2. PubMed ID: 33968811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are environmentally friendly firms more vulnerable during the COVID-19 pandemic?
    Zhang D; Fang Y
    J Clean Prod; 2022 Jun; 355():131781. PubMed ID: 35466288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of analyst attention on the firms' innovation paths from a life cycle perspective: Evidence from China.
    Yao J; Wang D
    Heliyon; 2023 Aug; 9(8):e18940. PubMed ID: 37636392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental regulation, firms' bargaining power, and firms' total factor productivity: evidence from China.
    Yang S; Wang C; Zhang H; Lu T; Yi Y
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):9341-9353. PubMed ID: 34499302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of COVID-19 on Japanese firms: mobility and resilience via remote work.
    Kawaguchi D; Kitao S; Nose M
    Int Tax Public Financ; 2022; 29(6):1419-1449. PubMed ID: 36092538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management or technology? Firms' embeddedness in dual talent flow networks and their innovation performance.
    Sun B; Ruan A; Peng B; Liu S
    Front Psychol; 2022; 13():1028818. PubMed ID: 36425841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How R&D intensive firms react to the COVID-19 pandemic: Evidence from a quasi-natural experiment.
    Pham THL; Nguyen DHT; Chu VT; Nguyen KD; Pham BT
    Heliyon; 2023 Sep; 9(9):e19329. PubMed ID: 37662736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leadership in a pandemic: Do more able managers keep firms out of trouble?
    Nguyen HT; Pham MH; Truong C
    J Behav Exp Finance; 2023 Mar; 37():100781. PubMed ID: 36568125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the growth impact of different eco-innovation business strategies.
    Caravella S; Crespi F
    Econ Polit (Bologna); 2022; 39(2):657-683. PubMed ID: 35422587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could more innovation output bring better financial performance? The role of financial constraints.
    Hai B; Yin X; Xiong J; Chen J
    Financ Innov; 2022; 8(1):6. PubMed ID: 35036293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CEOs' psychological trait and firms' adoption of blockchain technology: The role of hometown identity.
    Wang L; Xiao W; Xie S; Wei R
    Front Psychol; 2022; 13():1005249. PubMed ID: 36467173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustainable development goals as unifying narratives in large UK firms' Twitter discussions.
    Patuelli A; Saracco F
    Sci Rep; 2023 Apr; 13(1):7017. PubMed ID: 37120611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crisis Preparedness of Healthcare Manufacturing Firms during the COVID-19 Outbreak: Digitalization and Servitization.
    Zhang J; Qi L
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19's impacts on business activities and female workers: Empirical evidence from global developing economies.
    Wu R
    J Int Dev; 2022 Jul; ():. PubMed ID: 35942483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating the natural environment into tourism firms' business model for sustainability.
    Baiocco S; Paniccia PMA
    Environ Sci Pollut Res Int; 2023 Jun; 30(30):75015-75028. PubMed ID: 37209340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financing Constraints and Firm's Productivity Under the COVID-19 Epidemic Shock: Evidence of A-Shared Chinese Companies.
    Wong Z; Chen A; Taghizadeh-Hesary F; Li R; Kong Q
    Eur J Dev Res; 2023; 35(1):167-195. PubMed ID: 35194343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.